I don't want to believe that this news is true .........
-----------------------------------------------------------------------------------
The main world insulin supplier is withdrawing from the Greek market one of the most advanced medicines against diabetes.
The Danish company Novo Nordisk is thus responding to a government decree that orders a 25% reduction in the price of all medications.
The Greek Association against Diabetes condemned the decision as an example of "brutal capitalist blackmail."
More than 50,000 Greeks with diabetes use the product of Novo Nordisk, which is injected through a device similar to a fountain pen and is very easy to use.
A company spokesman said they were withdrawing Greece's product because forced prices were going to translate into losses for the company.
The pharmacist also feared that the 25% reduction had a rebound effect, as other countries use Greece as a key reference point when setting medicines prices.
"Insensitive"
Greece wants to cut his huge medical expenses as part of his efforts to reduce the debt he has plunged into the country.
Debts not paid with several international pharmaceutical companies total several billion dollars.Novo Nordisk states that the Greek state owes US $ 36 million.
Pavlos Panayotacos, father of a 10 -year -old girl named Neple, who suffers from diabetes, wrote to the president of Novo Nordisk criticizing his decision.
"As an economist I understand the importance of obtaining profits, but health care is more important than the balance sheets," he wrote.
"But as you should know, at this time Greece goes through a difficult economic and social situation, and you could not have acted less sensitively at a less timely time."
The Greek Association against Diabetes was much harder by qualifying the action of "brutal blackmail" and "violation of corporate social responsibility principles."
The president of Novo Nordisk, Lars Sorensen, responded to Mr. Panayotacos highlighting that he had been "the irresponsible management of finance by the Greek government that put us and our company in this difficult position."
Several patients with diabetes in Greece warned that people could die as a result of the situation.
But a pharmaceutical spokesman ruled out the possibility.He also informed that, to compensate, Novo Nordisk was going to make available an insulin product called Glucage.
